Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.
Rappaport SH, Clark JM, Delibert S, Maynard KM, Prasad P, Kaufman DC, Pietropaoli AP, Quill CM, Groth CM.
Rappaport SH, et al. Among authors: prasad p.
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1731-1733. doi: 10.1164/rccm.202006-2511LE.
Am J Respir Crit Care Med. 2020.
PMID: 32931713
Free PMC article.
No abstract available.